Novartis India's Stocks Fall after Nine Sessions of Increase; Stocks Up by 52% since August 31
Last Updated: 11th September 2026 - 04:47 pm
Shares of Novartis India fell on September 11, marking the end of nine days of rallies during which the stocks had risen 52% from August 31.
At the start of the day, the stocks made positive moves but fell back later. The stocks rose to ₹2,550, which is a 5% rise. As the day progressed, the stocks fell back, with Novartis India ending the day down 1.16% at ₹2,400.
Recent Rally Followed Trademark Acquisition
Much of the recent buying came after the company’s September 7 disclosure regarding the acquisition of the “Minipress” and “Minipres” trademarks.
Novartis India’s board approved the acquisition of the trademarks registered in India, along with certain related intellectual property rights, from Pfizer Inc USA and Pfizer Products Inc USA.
The transaction carries an aggregate consideration of ₹1,250 crore.
On the same day as the board approval, Novartis India entered into an asset purchase agreement and trademark assignment deeds with the two Pfizer entities to take the transaction forward.
The development had been followed by a sharp run in the stock. From August 31 through the nine-session rally, Novartis India shares gained 52% before giving up ground on September 11.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.